EGFR and non-small cell lung carcinoma: Moreover, we reveal that our immuno-PCR differentiates sEVs from liquid biopsies, i.e., malignant pleural effusion (MPE) fluid of patients with EGFR-driven NSCLC, from patients with different NSCLC genotypes as well as from PE fluid from patients with benign disease.